Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Cash Flow Quality Index
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Cash Flow Quality Index of 4794.41x as of September 2025. Operating cash flow of CN¥281.88 Million exceeds net income of CN¥58.79K, indicating high earnings quality where cash backs reported profits. Also explore how large is Shaanxi Meibang Pharmaceutical Group Co 's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Shaanxi Meibang Pharmaceutical Group Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Shaanxi Meibang Pharmaceutical Group Co 's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year earnings quality comparison for Shaanxi Meibang Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see Shaanxi Meibang Pharmaceutical Group Co (605033) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 7.61x | CN¥280.40 Million | CN¥36.86 Million | ▲ +30.8% |
| 2023 | 5.82x | CN¥334.79 Million | CN¥57.56 Million | ▲ +567.6% |
| 2022 | 0.87x | CN¥126.41 Million | CN¥145.09 Million | ▲ +200.7% |
| 2021 | -0.86x | CN¥-108.75 Million | CN¥125.74 Million | ▼ -190.9% |
| 2020 | 0.95x | CN¥74.88 Million | CN¥78.73 Million | ▼ -43.5% |
| 2019 | 1.68x | CN¥128.45 Million | CN¥76.26 Million | ▲ +489.3% |
| 2018 | 0.29x | CN¥16.96 Million | CN¥59.33 Million | ▼ -40.5% |
| 2017 | 0.48x | CN¥29.41 Million | CN¥61.22 Million | — |